OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study
Philippe Ruszniewski, Juan W. Valle, Catherine Lombard‐Bohas, et al.
Digestive and Liver Disease (2016) Vol. 48, Iss. 5, pp. 552-558
Open Access | Times Cited: 43
Philippe Ruszniewski, Juan W. Valle, Catherine Lombard‐Bohas, et al.
Digestive and Liver Disease (2016) Vol. 48, Iss. 5, pp. 552-558
Open Access | Times Cited: 43
Showing 26-50 of 43 citing articles:
Clinical utility of lanreotide Autogel<sup>®</sup> in gastroenteropancreatic neuroendocrine tumors
Rosa Maria Paragliola, Alessandro Prete, Giampaolo Papi, et al.
Drug Design Development and Therapy (2016) Vol. Volume 10, pp. 3459-3470
Open Access | Times Cited: 10
Rosa Maria Paragliola, Alessandro Prete, Giampaolo Papi, et al.
Drug Design Development and Therapy (2016) Vol. Volume 10, pp. 3459-3470
Open Access | Times Cited: 10
Lanreotide Depot to Treat Gastroenteropancreatic Neuroendocrine Tumors in a US Community Oncology Setting: A Prospective, Observational Study
Scott Paulson, David Ray, Sharan Aranha, et al.
Oncology and Therapy (2022) Vol. 10, Iss. 2, pp. 463-479
Open Access | Times Cited: 7
Scott Paulson, David Ray, Sharan Aranha, et al.
Oncology and Therapy (2022) Vol. 10, Iss. 2, pp. 463-479
Open Access | Times Cited: 7
PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK
Mohid S. Khan, Kathryn Cook, Martin O. Weickert, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 3
Open Access | Times Cited: 1
Mohid S. Khan, Kathryn Cook, Martin O. Weickert, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 3
Open Access | Times Cited: 1
Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals
Jesse D. Ortendahl, Sonia Pulgar, Beloo Mirakhur, et al.
ClinicoEconomics and Outcomes Research (2017) Vol. Volume 9, pp. 495-503
Open Access | Times Cited: 10
Jesse D. Ortendahl, Sonia Pulgar, Beloo Mirakhur, et al.
ClinicoEconomics and Outcomes Research (2017) Vol. Volume 9, pp. 495-503
Open Access | Times Cited: 10
Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review
Anna La Salvia, Alberto Portigliatti Pomeri, Irene Persano, et al.
Comprehensive Psychiatry (2021) Vol. 109, pp. 152244-152244
Open Access | Times Cited: 8
Anna La Salvia, Alberto Portigliatti Pomeri, Irene Persano, et al.
Comprehensive Psychiatry (2021) Vol. 109, pp. 152244-152244
Open Access | Times Cited: 8
A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours
Marine Perrier, Jean‐Yves Scoazec, Thomas Walter
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 3
Marine Perrier, Jean‐Yves Scoazec, Thomas Walter
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 3
OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogel
Vincent Hautefeuille, Thomas Walter, Christine Do Cao, et al.
European Journal of Endocrinology (2023) Vol. 189, Iss. 2, pp. 281-289
Open Access | Times Cited: 3
Vincent Hautefeuille, Thomas Walter, Christine Do Cao, et al.
European Journal of Endocrinology (2023) Vol. 189, Iss. 2, pp. 281-289
Open Access | Times Cited: 3
Cost-effectiveness of Lutetium [177Lu] oxodotreotide versus best supportive care with octreotide in patients with midgut neuroendocrine tumors in France
Oscar Leeuwenkamp, Jayne Smith-Palmer, R Ortiz, et al.
Journal of Medical Economics (2020) Vol. 23, Iss. 12, pp. 1534-1541
Open Access | Times Cited: 8
Oscar Leeuwenkamp, Jayne Smith-Palmer, R Ortiz, et al.
Journal of Medical Economics (2020) Vol. 23, Iss. 12, pp. 1534-1541
Open Access | Times Cited: 8
Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria
Anja Rinke, Christoph Maintz, Lothar Müller, et al.
Experimental and Clinical Endocrinology & Diabetes (2021) Vol. 129, Iss. 07, pp. 500-509
Open Access | Times Cited: 5
Anja Rinke, Christoph Maintz, Lothar Müller, et al.
Experimental and Clinical Endocrinology & Diabetes (2021) Vol. 129, Iss. 07, pp. 500-509
Open Access | Times Cited: 5
Perspectives of patients and physicians about neuroendocrine tumors. A qualitative study
Jordan Sibéoni, W Khannoussi, Emilie Manolios, et al.
Oncotarget (2018) Vol. 9, Iss. 18, pp. 14138-14147
Open Access | Times Cited: 4
Jordan Sibéoni, W Khannoussi, Emilie Manolios, et al.
Oncotarget (2018) Vol. 9, Iss. 18, pp. 14138-14147
Open Access | Times Cited: 4
A Budget Impact Model of the Addition of Telotristat Ethyl Treatment to the Standard of Care in Patients with Uncontrolled Carcinoid Syndrome
Kelly Fust, Michael Maschio, Michele Kohli, et al.
PharmacoEconomics (2020) Vol. 38, Iss. 6, pp. 607-618
Open Access | Times Cited: 4
Kelly Fust, Michael Maschio, Michele Kohli, et al.
PharmacoEconomics (2020) Vol. 38, Iss. 6, pp. 607-618
Open Access | Times Cited: 4
Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index
Sara Shaunfield, Kimberly Webster, Karen Kaiser, et al.
Neuroendocrinology (2020) Vol. 111, Iss. 9, pp. 850-862
Closed Access | Times Cited: 4
Sara Shaunfield, Kimberly Webster, Karen Kaiser, et al.
Neuroendocrinology (2020) Vol. 111, Iss. 9, pp. 850-862
Closed Access | Times Cited: 4
Impact of Specific Bowel Symptoms on Quality of Life in Patients with Midgut Neuroendocrine Tumours
Håkan Ohlsson, Gideon Wahlberg, Marlene Malmström, et al.
World Journal of Surgery (2021) Vol. 45, Iss. 9, pp. 2793-2803
Open Access | Times Cited: 4
Håkan Ohlsson, Gideon Wahlberg, Marlene Malmström, et al.
World Journal of Surgery (2021) Vol. 45, Iss. 9, pp. 2793-2803
Open Access | Times Cited: 4
A Systematic Review of Economic and Quality-of-Life Research in Carcinoid Syndrome
I‐Wen Pan, Daniel M. Halperin, Bumyang Kim, et al.
PharmacoEconomics (2021) Vol. 39, Iss. 11, pp. 1271-1297
Open Access | Times Cited: 3
I‐Wen Pan, Daniel M. Halperin, Bumyang Kim, et al.
PharmacoEconomics (2021) Vol. 39, Iss. 11, pp. 1271-1297
Open Access | Times Cited: 3
NETs of the Lung
Natalie Prinzi, Roberta Rossi, Giovanni Leuzzi, et al.
Springer eBooks (2021), pp. 163-178
Closed Access | Times Cited: 1
Natalie Prinzi, Roberta Rossi, Giovanni Leuzzi, et al.
Springer eBooks (2021), pp. 163-178
Closed Access | Times Cited: 1
PREF-NET: a patient preference and experience study of lanreotide autogel administered in the home versus hospital setting among patients with gastroenteropancreatic neuroendocrine tumours in the UK
Mohid S. Khan, Louise Davies, Melissa Back, et al.
Endocrine Abstracts (2022)
Open Access
Mohid S. Khan, Louise Davies, Melissa Back, et al.
Endocrine Abstracts (2022)
Open Access
Telotristat in the management of Carcinoid diarrhoea – A real world experience of patients from ENETs centre of excellence in Neuroendocrine tumours
Amardeep Khanna, Nicole Cianci, Husnain Shah, et al.
GastroHep (2021) Vol. 3, Iss. 5, pp. 291-297
Open Access
Amardeep Khanna, Nicole Cianci, Husnain Shah, et al.
GastroHep (2021) Vol. 3, Iss. 5, pp. 291-297
Open Access
Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?
Martyn Caplin
European Journal of Cancer Supplements (2021) Vol. 16, pp. 1-4
Open Access
Martyn Caplin
European Journal of Cancer Supplements (2021) Vol. 16, pp. 1-4
Open Access
